Thema: ScienceDaily
The pandemic pet boom was real. The happiness boost wasn’t
Locked-down Hungarians who gained or lost pets saw almost no lasting shift in mood or loneliness, and new dog owners actually felt less calm...
Parkinson’s may begin decades earlier — and your immune system might know first
Misbehaving T cells light up long before Parkinson’s symptoms show, zeroing in on vulnerable brain proteins. Their early surge could double as an alarm bell and a target for stop-it-early treatments.
Location matters: Belly fat compared to overall body fat more strongly linked to psoriasis...
Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than total body fat, particularly in...
Unusual carbon build-up found in lungs of COPD patients
Scientists have discovered that people with COPD have lung cells that contain over three times as much soot-like carbon as those of smokers without the disease. These overloaded cells are larger and trigger more inflammation, suggesting that pollution and carbon buildup not just smoking may drive the disease.
Boys who are overweight in their early teens risk passing on harmful epigenetic traits...
A new study suggests that boys who become overweight in their early teens risk damaging the genes of their future children, increasing their chances of developing asthma, obesity and low lung function.
Key player in childhood food allergies identified: Thetis cells
Thetis cells, a class of immune cells first described in 2022, play an essential and previously unknown role in suppressing inflammatory responses to food,...
Diagnosing Parkinson’s using a blood-based genetic signature
Researchers have identify a set of biomarkers that could someday make it easy to spot the disease in a patient's blood sample.
Novel rat model paves the way to advance COPD-associated cor pulmonale research
Researchers have developed a novel rat model that closely replicates the pathological features and physiological changes associated with human chronic obstructive pulmonary disease (COPD)-associated...
New drug shows promise for treating bronchiectasis
Results of a large, global clinical trial spanning five continents with over 1,700 patients with bronchiectasis has demonstrated benefits of an investigational, once-a-day pill called brenso catib as a therapy for the chronic lung condition. It may soon become the first-ever FDA-approved treatment for bronchiectasis.
New bioactive compound for difficult-to-treat allergies
Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in common that they are triggered by an...